BackAkari Therapeutics Plc Overview

Akari Therapeutics Plc Goodwill

Track Akari Therapeutics Plc's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00
100.00% YoYΔ $-8.43M vs prior year quarter

Peer average

Loading

Akari Therapeutics Plc Goodwill History

Loading

Akari Therapeutics Plc vs. peers: Goodwill Comparison

Loading

Akari Therapeutics Plc Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Akari Therapeutics Plc (AKTX) FAQ

As of the most recent data (March 2026), AKTX shows a goodwill of $0. That compares with $8.4M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AKTX's goodwill is now $0 (was $8.4M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Akari Therapeutics Plc is outperforming or lagging.

Tracking AKTX's goodwill over time shows whether Akari Therapeutics Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $8.4M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Akari Therapeutics Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $0) with ownership activity and broader fundamentals.

Akari Therapeutics Plc's goodwill is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.